Farther Finance Advisors’s VanEck Biotech ETF BBH Stock Holding History

Farther Finance Advisors’s Portfolio BBH Stock Details BBH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$98.8K	Hold	486	–	–	﹤0.01%	2711
2026 Q1	$92K	Buy	486 +285	+142%	+$54.9K	﹤0.01%	2572
2025 Q4	$38K	Hold	201	–	–	﹤0.01%	2992
2025 Q3	$33.3K	Buy	201 +80	+66%	+$13K	﹤0.01%	2702
2025 Q2	$18.5K	Hold	121	–	–	﹤0.01%	2727
2025 Q1	$18.6K	Sell	121 -85	-41%	-$13.8K	﹤0.01%	2421
2024 Q4	$32.3K	Buy	+206	New	+$34.7K	﹤0.01%	1873

Other funds holding BBH

HFAS

Hummer Financial Advisory Services Chicago, Illinois $152M AUM 20.1% 1-Year Est. Return

VIP

Value Investment Professionals New York $119M AUM

PAW

Plan A Wealth Lincoln, Nebraska $235M AUM 22.68% 1-Year Est. Return

FFN

Focus Financial Network Minneapolis, Minnesota $3.23B AUM 29.61% 1-Year Est. Return

CoreCap Advisors Southfield, Michigan $3.39B AUM 31.21% 1-Year Est. Return

Pacifica Partners Surrey, Canada $332M AUM 59.28% 1-Year Est. Return

Farther Finance Advisors's BBH Position: Q2 2026 in Review

Farther Finance Advisors held its VanEck Biotech ETF (BBH) position steady in Q2 2026 at 486 shares worth $98.8K. The position accounts for ﹤0.01% of the portfolio, ranked #2711.

Farther Finance Advisors first reported a position in BBH in Q4 2024 and has held it in 7 quarters since. 7 funds tracked by Wall St. Rank hold BBH as of Q2 2026.

Farther Finance Advisors held 486 shares of VanEck Biotech ETF worth $98.8K as of Q2 2026.
Farther Finance Advisors left its VanEck Biotech ETF share count unchanged in Q2 2026.
VanEck Biotech ETF made up ﹤0.01% of Farther Finance Advisors's portfolio in Q2 2026, its #2711 holding.
Farther Finance Advisors first reported a position in VanEck Biotech ETF in Q4 2024 and has held it in 7 quarters since.
7 funds tracked by Wall St. Rank held VanEck Biotech ETF as of Q2 2026.

Based on Farther Finance Advisors's 13F filing for Q2 2026, filed 17 Jul 2026.